Mqs Management LLC Biomarin Pharmaceutical Inc Transaction History

Mqs Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$74.43 - $92.22 $507,463 - $628,755	6,818 New	6,818 $561,000
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $9,783 - $10,865	115 Added 2.95%	4,015 $355,000
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $30,944 - $35,807	-357 Reduced 8.39%	3,900 $338,000
Q1 2023 May 05, 2023	BUY	$87.74 - $117.27 $373,509 - $499,218	4,257 New	4,257 $413,000
Q2 2022 Aug 05, 2022	SELL	$71.48 - $86.85 $48,463 - $58,884	-678 Reduced 13.42%	4,374 $362,000
Q1 2022 May 10, 2022	BUY	$74.28 - $92.69 $375,262 - $468,269	5,052 New	5,052 $390,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.